SUDA Pharmaceuticals

SUDA Pharmaceuticals Ltd (SUDA), based in Australia and the US, is a world leader in reformulating and delivering medication through the oral mucosa.

Patients typically take medication as pills, tablets or capsules yet less than 25% of the medication is absorbed into the bloodstream.

SUDA can increase the bioavailability of administered medications, which means it increases the amount of the drug absorbed by the body so is able to increase the effect of that drug.

SUDA has increased bioavailability up to 95%. This is a major step forward in the evolution of drug delivery technology.

Latest Media Releases

SUDA Appoints Dr Michael Baker CEO

27/11/2019 11:13:00

Michael Baker joins SUDA Pharmaceuticals from the leading Australian life science fund, Bioscience Managers, where he was based from 2017. As an Investment Manager, he was responsible for deal sourc…

Latest News